Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  ALK-Abello A/S       DK0060027142

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

ALK-Abello A/S : Share Buy-Back in ALK - week 27

07/03/2012| 04:53am US/Eastern
Recommend:
0

Copenhagen, 2012-07-03 09:56 CEST (GLOBE NEWSWIRE) --

On 14 May 2012, ALK-Abelló A/S ("ALK") initiated a share buy-back programme, cf. company announcement No. 14/2012. According to the programme, ALK will in the period from 15 May 2012 to 4 February 2013 purchase own shares for a maximum amount of DKK 75 million and no more than 200,000 shares corresponding to 2.0% of the current share capital of ALK. The share buy-back programme is initiated and structured in compliance with the EU Commission Regulation No. 2273/2003 of 22 December 2003 and thus ALK will publish the accumulated share buy-back under the programme every week.

The following transactions have been made under the programme: 

No of shares bought back Average transaction price Amount (DKK)
Accumulated, last announcement
18,213

6,598,306
26 June 2012 500 351.50 175,750
27 June 2012 192 350.00 67,200
28 June 2012 1,125 348.24 391,770
29 June 2012 476 348.41 165,843
2 July 2012 0 0.00 0
Accumulated under the programme
20,506

360.81

7,398,869


As of today, ALK's total holding of own shares is 378,223 shares of a nominal value of DKK 10, corresponding to 3.7% of the total number of issued shares of 10,128,360.

ALK-Abelló A/S

Jens Bager
President and CEO

For further information please contact:
Per Plotnikof, Investor Relations Director, tel. +45 4574 7527


distributed by
Recommend :
0
Partner Area
React to this article
 
Latest news on ALK-ABELLO A/S
05/08DJMERCK: FDA Accepts Application for Dissolvable Ragweed Allergy Pill
05/08 ALK-ABELLO A/S: License application for ragweed allergy immunotherapy tablet ac..
05/03 ALK-ABELLO A/S: Three-month interim report (Q1) 2013
04/30 ALK-ABELLO A/S: Release of three-month interim report (Q1) 2013: Investor and a..
04/29ALK-ABELLO A/S: quaterly earnings release
03/13 ALK-ABELLO A/S: ex-dividend day for annual dividend
03/12 ALK-ABELLO A/S: Grant of share options and conditional shares to members of the..
03/12 ALK-ABELLO A/S: Report on Management's transactions with ALK-Abelló A/S B share..
03/12 ALK-ABELLO A/S: Annual general meeting of ALK-Abelló A/S held on 12 March 2013
03/12 ALK-ABELLO A/S: ALK's partner, Merck, submits a BLA to the FDA for a marketing ..
Advertisement
Chart
Duration : Period :
ALK-Abello A/S Technical Analysis Chart | DK0060027142 | 4-Traders
Income Statement Evolution
ALK-Abello A_S : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.